Priority Date: 13.01.12 (US 201261586718P)

HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS.

  • Application ID: EP13701326
  • Status: █ GRANT OF PATENT INTENDED

Attorney

Employment test 11 - 50 employees
Missing person image thumb Missing person image thumb Missing person image thumb
Company dna witte weller and partner
operating since 1987
1188.88
Witte, Weller & Partner Pat...
Headquarter in Stuttgart
active in Legal Services, IP Consulting, and IP-related Communication Service

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 233 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 13.01.2012 - Priority Date (US 201261586718P)
  • 18.07.2013 - Publication A1 (WO2013106792)
  • 19.11.2014 - Publication A1 (EP2802568)